Advanced search
Publication Cover
Future Cardiology Volume 3, 2007 - Issue 2
Submit an article Journal homepage
89
Views
0
CrossRef citations to date
0
Altmetric
Review

Mechanical and Pharmacological Methods to Prevent Venous Thromboembolism

David BergqvistUppsala University Hospital Department of Surgical SciencesSE-751 85UppsalaSweden. Tex: +46186114633 Fax: +46186114632 [email protected]
Pages 213-224 | Published online: 26 Feb 2007

Bibliography

  • Geerts WH , PineoGF, HeitJAet al.: Prevention of venous thromboembolism. Presented at: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.Chest, 126, S338–S400 (2004).
  • Cardiovascular Disease Educational and Research Trust; Cyprus Cardiovascular Disease Educational and Research Trust; European Venous Forum; International Surgical Thrombosis Forum; International Union of Angiology; Union Internationale de Phlebologie: Prevention and treatment of venous thromboembolism. International Consensus Statement (guidelines according to scientific evidence). Int. Angiol., 25, 101–161 (2006).
  • Turpie AG , HirshJ, GentMet al.: Prevention of deep vein thrombosis in potential neurosurgical patients. A randomized trial comparing graduated compression stockings alone or graduated compression stockings plus intermittent pneumatic compression with control.Arch. Intern. Med., 149, 679–681 (1989).
  • Efficacy of oral anticoagulants compared with aspirin after infrainguinal bypass surgery (The Dutch Bypass Oral Anticoagulants or Aspirin Study): a randomised trial. Lancet, 355, 346–351 (2000).
  • Jackson MR , ClagettGP: Antithrombotic therapy in peripheral arterial occlusive disease.Chest, 119, S283–S299 (2001).
  • Jackson MR , JohnsonWC, WillifordWOet al.: The effect of anticoagulation therapy and graft selection on the ischemic consequences of femoropopliteal bypass graft occlusion: results from a multicenter randomized clinical trial. J. Vasc. Surg., 35, 292–298 (2002).
  • Angelides NS , NicolaidesAN, FernandesJet al.: Deep venous thrombosis in patients having aorto-iliac reconstruction.Br. J. Surg., 64, 517–518 (1977).
  • Bergqvist D : Update on in hospital venous thromboembolism prophylaxis.Eur. J. Vasc. Endovasc. Surg. PMID 17236793 (2007) (Epub ahead of print).
  • Hollyoak M , WoodruffP, MullerMet al.: Deep venous thrombosis in postoperative vascular surgical patients: a frequent finding without prophylaxis.J. Vasc. Surg., 34, 656–660 (2001).
  • Eliasson Å, Bergqvist D, Bjórck M, Sternby NH, Ögren M: Incidence and risk of venous thromboembolism in patients with verified arterial thrombosis: a population study based on 23796 consecutive autopsies. J. Thromb. Haemost., 4(9), 1886–1890 (2006).
  • Prandoni P , GhirarduzziA, PrinsMHet al.: Venous thromboembolism and the risk of subsequent symptomatic atherosclerosis.J. Thromb. Haemost., 4, 1891–1896 (2006).
  • Prandoni P , BiloraF, MarchioriAet al.: An association between atherosclerosis and venous thrombosis.N. Engl. J. Med., 348, 1435–1441 (2003).
  • Lindberg F , BergqvistD, RasmussenI: Incidence of thromboembolic complications after laparoscopic cholecystectomy: review of the literature.Surg. Laparosc. Endosc., 7, 324–331 (1997).
  • Hjelmqvist B : Complications of laparoscopic cholecystectomy as recorded in the Swedish laparoscopy registry.Eur. J. Surg. (Suppl. 585), 18–21 (2000).
  • Bounameaux H , DidierD, PolatOet al.: Antithrombotic prophylaxis in patients undergoing laparoscopic cholecystectomy.Thromb. Res., 86, 271–273 (1997).
  • Lindberg F , BjorckM, RasmussenIet al.: Low frequency of phlebographic deep vein thrombosis after laparoscopic cholecystectomy – a pilot study.Clin. Appl. Thromb. Hemost., 12, 421–426 (2006).
  • Wilson D , CookeEA, McNallyMAet al.: Altered venous function and deep venous thrombosis following proximal femoral fracture.Injury, 33, 33–39 (2002).
  • Scurr JH , Coleridge-SmithPD, HastyJH: Deep venous thrombosis: a continuing problem.Br. Med. J., 297, 28 (1988).
  • Planes A , VochelleN, DarmonJYet al.: Risk of deep-venous thrombosis after hospital discharge in patients having undergone total hip replacement: double-blind randomised comparison of enoxaparin versus placebo.Lancet, 348, 224–228 (1996).
  • Dahl OE , AndreassenG, AspelinTet al.: Prolonged thromboprophylaxis following hip replacement surgery – results of a double-blind, prospective, randomised, placebo-controlled study with dalteparin (Fragmin).Thromb. Haemost., 77, 26–31 (1997).
  • White RH , RomanoPS, ZhouHet al.: Incidence and time course of thromboembolic outcomes following total hip or knee arthroplasty.Arch. Intern. Med., 158, 1525–1531 (1998).
  • Paiement GD , WessingerSJ, HarrisWH: Cost-effectiveness of prophylaxis in total hip replacement.Am. J. Surg., 161, 519–524 (1991).
  • Eikelboom JW , QuinlanDJ, DouketisJD: Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomised trials.Lancet, 358, 9–15 (2001).
  • Hull RD , PineoGF, SteinPDet al.: Extended out-of-hospital low-molecular-weight heparin prophylaxis against deep venous thrombosis in patients after elective hip arthroplasty: a systematic review.Ann. Intern. Med., 135, 858–869 (2001).
  • Douketis JD , EikelboomJW, QuinlanDJet al.: Short-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of prospective studies investigating symptomatic outcomes. Arch. Intern. Med., 162, 1465–1471 (2002).
  • Cohen AT , BaileyCS, AlikhanR, CooperDJ: Extended thromboprophylaxis with low molecular weight heparin reduces symptomatic venous thromboembolism following lower limb arthroplasty – a meta-analysis.Thromb. Haemost., 85, 940–941 (2001).
  • Lassen MR , BorrisLC, NakovRL: Use of the low-molecular-weight heparin reviparin to prevent deep-vein thrombosis after leg injury requiring immobilization.N. Engl. J. Med., 347, 726–730 (2002).
  • Jorgensen PS , WarmingT, HansenKet al.: Low molecular weight heparin (Innohep) as thromboprophylaxis in outpatients with a plaster cast: a venografic controlled study.Thromb. Res., 105, 477–480 (2002).
  • Powers PJ , GentM, JayRMet al.: A randomized trial of less intense postoperative warfarin or aspirin therapy in the prevention of venous thromboembolism after surgery for fractured hip.Arch. Intern. Med., 149, 771–774 (1989).
  • Snook GA , ChrismanOD, WilsonTC: Thromboembolism after surgical treatment of hip fractures.Clin. Orthop. Relat. Res.21–24 (1981).
  • Agnelli G , CosmiBet al., Di Filippo P : A randomised, double-blind, placebo-controlled trial of dermatan sulphate for prevention of deep vein thrombosis in hip fracture. Thromb. Haemost., 67, 203–208 (1992).
  • Borgstrom S , GreitzTet al., van der Linden W : Anticoagulant prophylaxis of venous thrombosis in patients with fractured neck of the femur. A controlled clinical trial using venous phlebography. Acta Chir. Scand., 129, 500–508 (1965).
  • Hamilton HW , CrawfordJS, GardinerJH, WileyAM: Venous thrombosis in patients with fracture of the upper end of the femur. A phlebographic study of the effect of prophylactic anticoagulation.J. Bone Joint Surg. Br., 52, 268–289 (1970).
  • Lowe GD , CampbellAF, MeekDRet al.: Subcutaneous ancrod in prevention of deep-vein thrombosis after operation for fractured neck of femur.Lancet, 2, 698–700 (1978).
  • Jorgensen P , StransbergC, Wille-JorgensenP: Early preoperative thromboprophylaxis with Klexane in hip fracture surgery: a placebo-controlled study.Clin. Appl. Thromb. Hemost., 4, 140–142 (1998).
  • Consortium for spinal cord medicine. Prevention of thromboembolism in spinal cord injury. J. Spinal Cord. Med., 20, 259–283 (1997).
  • Geerts WH , CodeKI, JayRMet al.: A prospective study of venous thromboembolism after major trauma.N. Engl. J. Med., 331, 1601–1606 (1994).
  • Gallus AS , HirshJ, TutleRJet al.: Small subcutaneous doses of heparin in prevention of venous thrombosis.N. Engl. J. Med., 288, 545–551 (1973).
  • Belch JJ , LoweGD, WardAGet al.: Prevention of deep vein thrombosis in medical patients by low-dose heparin.Scott. Med. J., 26, 115–117 (1981).
  • Cade JF : High risk of the critically ill for venous thromboembolism.Crit. Care Med., 10, 448–450 (1982).
  • Dahan R , HoulbertD, CaulinCet al.: Prevention of deep vein thrombosis in elderly medical in-patients by a low molecular weight heparin: a randomized double-blind trial.Haemostasis, 16, 159–164 (1986).
  • Samama MM , CohenAT, DarmonJYet al.: A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group.N. Engl. J. Med., 341, 793–800 (1999).
  • Leizorovicz A , CohenAT, TurpieAGet al.: Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients.Circulation, 110, 874–879 (2004).
  • Prandoni P : Acquired risk factors of venous thromboembolism in medical patients.Pathophysiol. Haemost. Thromb., 35, 128–132 (2006).
  • Torngren S , RiegerA: Prophylaxis of deep venous thrombosis in colorectal surgery.Dis. Colon Rectum, 25, 563–566 (1982).
  • Torngren S , HagglundG, MolinK, RiegerA: Postoperative deep venous thrombosis and infectious complications. A clinical study of patients undergoing colo-rectal surgery.Scand. J. Infect. Dis., 12, 123–127 (1980).
  • Sajid MS , TaiNR, GoliGet al.: Knee versus thigh length graduated compression stockings for prevention of deep venous thrombosis: a systematic review.Eur. J. Vasc. Endovasc. Surg., 32, 730–736 (2006).
  • Williams LA , OwenTD: Above-knee versus below-knee stockings in total knee arthroplasty.Ann. R. Coll. Surg. Engl., 88, 302–305 (2006).
  • Hameed MF , BrowseDJ, ImmelmanEJ, GoldbergPA: Should knee-length replace thigh-length graduated compression stockings in the prevention of deep-vein thrombosis?S. Afr. J. Surg., 40, 15–16 (2002).
  • Benko T , CookeEA, McNallyMA, MollanRA: Graduated compression stockings: knee length or thigh length.Clin. Orthop.197–203 (2001).
  • Wells PS , LensingAW, HirshJ: Graduated compression stockings in the prevention of postoperative venous thromboembolism. A meta-analysis.Arch. Intern. Med., 154, 67–72 (1994).
  • Agu O , HamiltonG, BakerD: Graduated compression stockings in the prevention of venous thromboembolism.Br. J. Surg., 86, 992–1004 (1999).
  • Amaragiri SV , LeesTA: Elastic compression stockings for prevention of deep vein thrombosis.Cochrane Database Syst. Rev.CD001484 (2000).
  • Kay TW , MartinFI: Heel ulcers in patients with long-standing diabetes who wear antiembolism stockings.Med. J. Aust., 145, 290–291 (1986).
  • Merrett ND , HanelKC: Ischaemic complications of graduated compression stockings in the treatment of deep venous thrombosis.Postgrad. Med. J., 69, 232–234 (1993).
  • Bergqvist D , LjungnerH, NilssonM: Venous emptying from the calf. Methodologic report and effect of intermittent pneumatic compression.Acta Chir. Scand., 148, 669–673 (1982).
  • Anderson DR , WilsonSJ, BlundellJet al.: Comparison of a nomogram and physician-adjusted dosage of warfarin for prophylaxis against deep-vein thrombosis after arthroplasty.J. Bone Joint Surg. Am., A84, 1992–1997 (2002).
  • Mismetti P , LaporteS, ZuffereyPet al.: Prevention of venous thromboembolism in orthopedic surgery with vitamin K antagonists: a meta-analysis.J. Thromb. Haemost., 2, 1058–1070 (2004).
  • Hirsh J , RaschkeR: Heparin and low-molecular-weight heparin: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.Chest, 126, S188–S203 (2004).
  • Collins R , ScrimgeourA, YusufS, PetoR: Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery.N. Engl. J. Med., 318, 1162–1173 (1988).
  • Nurmohamed MT , RosendaalFR, BullerHRet al.: Low-molecular-weight heparin versus standard heparin in general and orthopaedic surgery: a meta-analysis.Lancet, 340, 152–156 (1992).
  • Breddin HK : Low molecular weight heparins in the prevention of deep-vein thrombosis in general surgery.Semin. Thromb. Hemost., 25(Suppl. 3), 83–89 (1999).
  • Jorgensen LN , Wille-JorgensenP, HauchO: Prophylaxis of postoperative thromboembolism with low molecular weight heparins.Br. J. Surg., 80, 689–704 (1993).
  • Koch A , ZieglerS, BreitschwerdtH, VictorN: Low molecular weight heparin and unfractionated heparin in thrombosis prophylaxis: meta-analysis based on original patient data.Thromb. Res., 102, 295–309 (2001).
  • Koch A , BougesS, ZieglerSet al.: Low molecular weight heparin and unfractionated heparin in thrombosis prophylaxis after major surgical intervention: update of previous meta- analyses.Br. J. Surg., 84, 750–759 (1997).
  • Leizorovicz A , HaughMC, ChapuisFRet al.: Low molecular weight heparin in prevention of perioperative thrombosis. Br. Med. J., 305, 913–920 (1992).
  • Mismetti P , LaporteS, DarmonJYet al.: Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery.Br. J. Surg., 88, 913–930 (2001).
  • Palmer AJ , SchrammW, KirchhofB, BergemannR: Low molecular weight heparin and unfractionated heparin for prevention of thrombo-embolism in general surgery: a meta-analysis of randomised clinical trials.Haemostasis, 27, 65–74 (1997).
  • Wille-Jorgensen P , RasmussenMS, AndersenBR, BorlyL: Heparins and mechanical methods for thromboprophylaxis in colorectal surgery.Cochrane Database Syst. Rev.CD001217 (2001).
  • Pezzuoli G et al. , Neri Serneri GG, Settembrini P : Prophylaxis of fatal pulmonary embolism in general surgery using low-molecular weight heparin Cy 216: a multicentre, double-blind, randomized, controlled, clinical trial versus placebo (STEP). STEP-Study Group. Int. Surg., 74, 205–210 (1989).
  • Marassi A , BalzanoG, MariGet al.: Prevention of postoperative deep vein thrombosis in cancer patients. A randomized trial with low molecular weight heparin (CY 216).Int. Surg., 78, 166–170 (1993).
  • Bergqvist D , FlordalPA, FribergBet al.: Thromboprophylaxis with a low molecular weight heparin (tinzaparin) in emergency abdominal surgery. A double-blind multicenter trial.VASA, 25, 156–160 (1996).
  • Warwick D , PerezJ, VickeryC, BannisterG: Does total hip arthroplasty predispose to chronic venous insufficiency?J. Arthroplasty, 11, 529–533 (1996).
  • Bergqvist D , BurmarkUS, FlordalPAet al.: Low molecular weight heparin started before surgery as prophylaxis against deep vein thrombosis: 2500 versus 5000 XaI units in 2070 patients.Br. J. Surg., 82, 496–501 (1995).
  • Leonardi MJ , McGoryML, KoCY: The rate of bleeding complications after pharmacologic deep venous thrombosis prophylaxis: a systematic review of 33 randomized controlled trials.Arch. Surg., 141, 790–797 (2006).
  • Weitz JI , HirshJ, SamamaMM: New anticoagulant drugs: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.Chest, 126, S265–S286 (2004).
  • Turpie AG , BauerKA, ErikssonBI, LassenMR: Superiority of fondaparinux over enoxaparin in preventing venous thromboembolism in major orthopedic surgery using different efficacy end points.Chest, 126, 501–508 (2004).
  • Turpie AG , ErikssonBI, BauerKA, LassenMR: New pentasaccharides for the prophylaxis of venous thromboembolism: clinical studies.Chest, 124, S371–S378 (2003).
  • Lassen MR , BauerKA, ErikssonBI, TurpieAG: Postoperative fondaparinux versus preoperative enoxaparin for prevention of venous thromboembolism in elective hip-replacement surgery: a randomised double-blind comparison.Lancet, 359, 1715–1720 (2002).
  • Turpie AG , BauerKA, ErikssonBI, LassenMR: Postoperative fondaparinux versus postoperative enoxaparin for prevention of venous thromboembolism after elective hip-replacement surgery: a randomised double-blind trial.Lancet, 359, 1721–1726 (2002).
  • Bauer KA , ErikssonBI, LassenMR, TurpieAG: Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery.N. Engl. J. Med., 345, 1305–1310 (2001).
  • Eriksson BI , BauerKA, LassenMR, TurpieAG: Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgery.N. Engl. J. Med., 345, 1298–1304 (2001).
  • Agnelli G , BergqvistD, CohenATet al.: Randomized clinical trial of postoperative fondaparinux versus perioperative dalteparin for prevention of venous thromboembolism in high-risk abdominal surgery.Br. J. Surg., 92, 1212–1220 (2005).
  • Smith SF , BiggsMT, SekhonLH: Risk factors and prophylaxis for deep venous thrombosis in neurosurgery.Surg. Technol. Int., 14, 69–76 (2005).
  • Iorio A , AgnelliG: Low-molecular-weight and unfractionated heparin for prevention of venous thromboembolism in neurosurgery: a meta-analysis.Arch. Intern. Med., 160, 2327–2332 (2000).
  • Geerts WH , JayRM, CodeKIet al.: A comparison of low-dose heparin with low-molecular-weight heparin as prophylaxis against venous thromboembolism after major trauma.N. Engl. J. Med., 335, 701–707 (1996).
  • Elliott CG , DudneyTM, EggerMet al.: Calf-thigh sequential pneumatic compression compared with plantar venous pneumatic compression to prevent deep-vein thrombosis after non-lower extremity trauma.J. Trauma, 47, 25–32 (1999).
  • Kamphuisen PW , AgnelliG, SebastianelliM: Prevention of venous thromboembolism after acute ischemic stroke.J. Thromb. Haemost., 3, 1187–1194 (2005).
  • Eriksson BI , LassenMR: Duration of prophylaxis against venous thromboembolism with fondaparinux after hip fracture surgery: a multicenter, randomized, placebo-controlled, double-blind study.Arch. Intern. Med., 163, 1337–1342 (2003).
  • Bergqvist D , AgnelliG, CohenATet al.: Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer.N. Engl. J. Med., 346, 975–980 (2002).
  • Rasmussen MS , JorgensenLN, Wille-JorgensenPet al.: Prolonged prophylaxis with dalteparin to prevent late thromboembolic complications in patients undergoing major abdominal surgery: a multicenter randomized open-label study.J. Thromb. Haemost., 4, 2384–2390 (2006).
  • Vandermeulen EP , Van Aken H, Vermylen J: Anticoagulants and spinal-epidural anesthesia. Anesth. Analg., 79, 1165–1177 (1994).
  • Horlocker TT , WedelDJ, BenzonHet al.: Regional anesthesia in the anticoagulated patient: defining the risks (the second ASRA Consensus Conference on Neuraxial Anesthesia and Anticoagulation).Reg. Anesth. Pain Med., 28, 172–197(2003).
  • Wysowski DK , TalaricoL, BacsanyiJ, BotsteinP: Spinal and epidural hematoma and low-molecular-weight heparin.N. Engl. J. Med., 338, 1774–1775 (1998).
  • Bergqvist D , WiklundL: Caution for prophylaxis of thrombosis in connection with spinal anesthesia. Risk of hemorrhage when low-molecular-weight heparin is administered in epidural/spinal anesthesia.Lakartidningen, 97, 5762–5765 (2000).
  • Horlocker TT : Low molecular weight heparin and neuraxial anesthesia.Thromb. Res., 101, V141–V154 (2001).
  • Lumpkin MM : FDA public health advisory.Anesthesiology, 88, A27–A28 (1998).
  • Nicolaides AN , KakkarVV, RenneyJTet al.: Myocardial infarction and deep-vein thrombosis. Br. Med. J., 1, 432–434 (1971).
  • Handley AJ , EmersonPA, FlemingPR: Heparin in the prevention of deep vein thrombosis after myocardial infarction.Br. Med. J., 2, 436–438 (1972).
  • Warlow C , TerryG, KenmureACet al.: A double-blind trial of low doses of subcutaneous heparin in the prevention of deep-vein thrombosis after myocardial infarction.Lancet, 2, 934–936 (1973).
  • Clagett GP , ReischJS: Prevention of venous thromboembolism in general surgical patients. Results of meta-analysis.Ann. Surg., 208, 227–240 (1988).
  • Lassen M , BorrisL: Thromboprophylaxis in hip fracture patients. In: Prevention of Venous Thromboembolism. Comerota AJ, Bergqvist D, Nicoalides A, Scurr DS (Eds). Med-Orion, London, UK 281–295 (1994).
  • Ansari S , WarwickD, AckroydCE, NewmanJH: Incidence of fatal pulmonary embolism after 1390 knee arthroplasties without routine prophylactic anticoagulation, except in high-risk cases.J. Arthroplasty, 12, 599–602 (1997).
  • Montgomery KD , GeertsWH, PotterHG, HelfetDL: Thromboembolic complications in patients with pelvic trauma.Clin. Orthop.68–87 (1996).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.